纤维化
肾脏疾病
脂质代谢
β氧化
脂肪酸代谢
肾
生物
炎症
细胞内
转录组
细胞生物学
新陈代谢
癌症研究
内分泌学
内科学
医学
生物化学
免疫学
基因表达
基因
作者
Hyun Mi Kang,Seon Ho Ahn,Peter S. Choi,Yi-An Ko,Seung Hyeok Han,Frank Chinga,Ae Seo Deok Park,Jianling Tao,Kumar Sharma,James Pullman,Erwin P. Böttinger,Ira J. Goldberg,Katalin Suszták
出处
期刊:Nature Medicine
[Springer Nature]
日期:2014-11-24
卷期号:21 (1): 37-46
被引量:1170
摘要
A new study shows that reduced fat metabolism in renal tubule cells contributes to kidney fibrosis. Renal fibrosis is the histological manifestation of a progressive, usually irreversible process causing chronic and end-stage kidney disease. We performed genome-wide transcriptome studies of a large cohort (n = 95) of normal and fibrotic human kidney tubule samples followed by systems and network analyses and identified inflammation and metabolism as the top dysregulated pathways in the diseased kidneys. In particular, we found that humans and mouse models with tubulointerstitial fibrosis had lower expression of key enzymes and regulators of fatty acid oxidation (FAO) and higher intracellular lipid deposition compared to controls. In vitro experiments indicated that inhibition of FAO in tubule epithelial cells caused ATP depletion, cell death, dedifferentiation and intracellular lipid deposition, phenotypes observed in fibrosis. In contrast, restoring fatty acid metabolism by genetic or pharmacological methods protected mice from tubulointerstitial fibrosis. Our results raise the possibility that correcting the metabolic defect in FAO may be useful for preventing and treating chronic kidney disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI